FPS has announced the delivery of a complex project that combines high containment within aseptic conditions.

It is composed by an N°2 Agitated Nutsche Filter Dryers (ANFD) system (respectively in AISI316L and HC22 materials) with integrated sampling, discharge, milling and packing-off station suitable to handle OEB4 dry product under sterile conditions.

Discharged product can be moved to final dispensing containment system for the preparation of final product in different packages.

As an alternative in the case of ultra-fine powder requirement, the product after preliminary drying and milling can be moved to dedicated micronisation and final dispensing isolator (with integrated FPS spiral Jetmill type PilotMill-6).

Key features of this system are:

  • Multi-chamber design providing a defined barrier between the process and surrounding environment.
  • Full access to the micronisation unit and the dispensing station installed inside the isolator.
  • Glove ports arrangement to provide the best ergonomics and maximum viewing of all process operations.
  • Positive/negative pressure regime between an enclosure and the surrounding environment to ensure all potential contamination is kept inside and required sterility level is assured.

FPS’ sales director and micronisation expert Eng Stefano Butti says: “It is a plant where the product is processed in conditions of high containment and asepsis, starting from its filtration and drying and passing through the milling, micronisation and final dispensing.

“All process steps and control system were managed entirely by us as main contractor, both for isolators and for the various process machines. The success of this challenge was certainly due to the experience gained in similar projects and the ability to combine these experiences, even in a critical way, with the aim of further improving what has already been done.”

A dedicated team worked closely with the client throughout the project to ensure that all specific requirements were met (sterility, containment, process performance), and superior quality of manufacture and containment levels were maintained.

Eng Butti also mentions the latest FPS news: “FPS is proud to announce the opening of the US commercial site, based in Philadelphia, which will enable us to offer a more accurate service in a very important market for the pharmaceutical industry.

“The modernisation of the Fiorenzuola d’Arda production site is completed, and thanks to these new spaces, FPS will offer its customers the opportunity to take part in some workshops dedicated to micronisation and containment. In the coming months, dates and all details for registration will be available on our website.”